Monte Meltzer, MD
Dermatology · Berlin, MDNPI 1861418840
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $191,250 of the $220,400 with a category attached, or 86.8%. Lilly USA, LLC accounts for 78.7% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $135,866 and has fallen 99.9% since, to $158 in 2024. Among dermatology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 363 payments — averaging $607.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$173K
- Novartis$45K
- Johnson & Johnson$365
- AbbVie$355
- LEO Pharma Inc.$248
- Sun Pharmaceutical Industries Inc.$234
- plus $1K from 16 others
What the payments were for
- Consulting fees$10,8505%
- Speaking & faculty fees$191,25087%
- Travel & lodging$11,9715%
- Food & beverage$6,0083%
- Education$3210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 209 | $173,475 |
| Novartis | 64 | $44,553 |
| Johnson & Johnson | 11 | $365 |
| AbbVie | 13 | $355 |
| LEO Pharma Inc. | 12 | $248 |
| Sun Pharmaceutical Industries Inc. | 11 | $234 |
| Incyte Corporation | 5 | $208 |
| UCB, Inc. | 5 | $173 |
| Sanofi | 8 | $133 |
| E.r. Squibb & Sons, L.L.C. | 5 | $124 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Bristol Myers Squibb | 1 | $91 |
| Galderma Laboratories, L.p. | 3 | $59 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $44 |
| Sebela Pharmaceuticals Inc. | 2 | $44 |
| Almirall LLC | 2 | $41 |
| Boehringer Ingelheim | 1 | $39 |
| Janssen Scientific Affairs, LLC | 1 | $32 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| VYNE Pharmaceuticals Inc. | 1 | $21 |
| Dermavant Sciences, Inc. | 1 | $19 |
| Amgen | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$220,400 in reported general payments places this provider in the 95th percentile of 306 dermatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $76,181 |
| Clobetasol Propionate | 11 | $871 |
| Doxycycline Hyclate | 13 | $818 |
| Triamcinolone Acetonide | 13 | $140 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Berlin
- Benjamin LockshinSilver Spring$4M
- Shawn KwatraBaltimore$1.1M
- Chesahna Kindred WeaverMarriottsville$837K
- Oanh LauringNottingham$763K
- Ronald PrussickN Bethesda$620K
- Rebecca KazinChevy Chase$342K
- Susan WalkerBethesda$221K
- Valerie CallenderGlenn Dale$183K
- David StrobelCatonsville$180K
- Natalia BilesMillersville$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.